HAOHAI BIOTEC acquires 19.8% of Ruiji Bio for a consideration of 38.35 million RMB
AASTOCKS
HAOHAI BIOTEC (06826.HK) announced the acquisition of a 19.8% stake in Ruiji Biotech from an independent third party. The latter's products are mainly used in the fields of orthopedics and ophthalmology, with a cash consideration of RMB 38.35 million, which will be paid using internal resources
